VCM
FLGT icon

Versant Capital Management’s Fulgent Genetics FLGT Stock Holding History

Versant Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.5K Sell
997
-1,694
-63% -$28.7K ﹤0.01% 1912
2026
Q1 		$42.8K Buy
2,691
+1,234
+85% +$26.8K ﹤0.01% 1333
2025
Q4 		$38.3K Hold
1,457
– – ﹤0.01% 1231
2025
Q3 		$32.9K Sell
1,457
-663
-31% -$13.7K ﹤0.01% 1277
2025
Q2 		$42.1K Buy
2,120
+694
+49% +$13.5K 0.01% 1074
2025
Q1 		$24.1K Buy
1,426
+434
+44% +$7.39K ﹤0.01% 1245
2024
Q4 		$18.3K Buy
992
+506
+104% +$9.88K ﹤0.01% 1079
2024
Q3 		$10.6K Buy
486
+148
+44% +$3.31K ﹤0.01% 1041
2024
Q2 		$6.63K Buy
338
+210
+164% +$4.38K ﹤0.01% 1131
2024
Q1 		$2.78K Hold
128
– – ﹤0.01% 1247
2023
Q4 		$3.7K Buy
128
+81
+172% +$2.17K ﹤0.01% 1080
2023
Q3 		$1.26K Sell
47
-317
-87% -$10.8K ﹤0.01% 1465
2023
Q2 		$13.5K Sell
364
-85
-19% -$2.96K ﹤0.01% 656
2023
Q1 		$14K Buy
+449
New +$14.4K ﹤0.01% 617

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Versant Capital Management's FLGT Position: Q2 2026 in Review

Versant Capital Management reduced its Fulgent Genetics (FLGT) stake by 63% in Q2 2026, selling an estimated $28.7K and leaving 997 shares worth $20.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1912.

Versant Capital Management first reported a position in FLGT in Q1 2023 and has held it in 14 quarters since. The position peaked at $42.8K in Q1 2026. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Versant Capital Management held 997 shares of Fulgent Genetics worth $20.5K as of Q2 2026.
  • Versant Capital Management sold 1,694 Fulgent Genetics shares in Q2 2026, an estimated $28.7K.
  • Fulgent Genetics made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1912 holding.
  • Versant Capital Management first reported a position in Fulgent Genetics in Q1 2023 and has held it in 14 quarters since.
  • Versant Capital Management's Fulgent Genetics position peaked at $42.8K in Q1 2026.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.